Teva Pharmaceuticals: Loss of profit not 'irreparable harm' to Teva: Supreme Court
Teva Pharmaceuticals is likely to lose millions of dollars in revenue when a court removes the patent next month on its popular multiple sclerosis drug Copaxone.
Read full article »
Teva Generics engages in manufacturing and distribution of generic medicines.
Read more